source Post navigation Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of Novel Cell Therapy for the Treatment of Type 1 Diabetes – Yahoo Finance Creative Medical Technology Secures IRB Approval for Diabetes Treatment Trial; Shares Surge – Marketscreener.com